TipRanks
Go Ultimate55% OFF

Chemcon Speciality Chemicals Ltd (CHEMCON) AI Stock Analysis

IN:CHEMCON

Chemcon Speciality Chemicals Ltd

(NSE:CHEMCON)

Select Model
Rating:63Neutral
Price Target:INR 240.00â–²(30.54% Upside)
Action:reiterated
Date:09/06/26

Solid balance sheet and bullish technical momentum are key strengths boosting the score, while income volatility and moderate valuation are moderating factors.

Positive Factors
Low LeverageConservative leverage gives Chemcon financial flexibility to fund operations and selective growth without excessive reliance on borrowing. A modest debt burden also reduces interest and refinancing pressure, helping the company remain more resilient if specialty-chemical demand or profitability weakens.
Negative Factors
Margin CompressionThe sharp deterioration in gross margin materially reduces earnings power and leaves less profit from each unit of sales. If the lower margin profile persists, Chemcon may have less capacity to reinvest, withstand cost pressure, or translate revenue growth into durable bottom-line expansion.

Chemcon Speciality Chemicals Ltd (CHEMCON) vs. iShares MSCI India ETF (INDA)

-50%-40%-30%-20%-10%0%10%IN:CHEMCON-22.32%INDA-12.02%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
INR 6.66B
Dividend Yield
3.53%
Average Volume (3M)
4,449
Price to Earnings (P/E)
22.3
Beta (1Y)
0.90
Revenue Growth
22.25%
EPS Growth
20.33%
Country
India
Employees
238
Sector
General
Sector Strength
55
Industry
Chemicals - Specialty

Chemcon Speciality Chemicals Ltd Business Overview & Revenue Model

Company Description

Founded in 1988 and headquartered in Vadodara, India, Chemcon Speciality Chemicals Limited is a producer and vendor of a diverse range of chemical products. The company primarily focuses on manufacturing pharmaceutical intermediates, silanes, and che...

How the Company Makes Money

Chemcon primarily makes money by manufacturing and selling specialty chemicals to business customers (B2B). Its revenue model is driven by (1) product sales from its specialty chemicals portfolio (including HMDS and other inorganic specialty chemical...

Chemcon Speciality Chemicals Ltd Financial Statement Overview

Summary

Mixed results: revenue volatility and declining profits in recent years balanced by strong equity position, low debt, and recent improvements in operating and free cash flows.

Income Statement

45Neutral

Balance Sheet

75Positive

Cash Flow

55Neutral
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue2.65B2.40B2.07B2.67B3.01B2.57B
Gross Profit626.60M524.77M869.50M758.95M1.27B1.17B
EBITDA461.64M456.25M328.58M400.64M840.11M908.34M
Net Income299.46M235.98M244.52M191.93M551.10M627.57M
Balance Sheet
Total Assets5.38B5.68B5.54B5.45B5.53B4.98B
Cash, Cash Equivalents and Short-Term Investments1.87B1.96B1.51B230.80M604.87M1.12B
Total Debt272.57M531.37M246.90M427.39M640.15M360.20M
Total Liabilities597.76M844.38M532.81M688.34M959.98M808.06M
Stockholders Equity4.78B4.83B5.01B4.76B4.57B4.17B
Cash Flow
Free Cash Flow0409.59M309.45M-308.77M-334.54M241.36M
Operating Cash Flow0501.51M405.17M119.64M127.43M742.22M
Investing Cash Flow0-460.09M-189.15M-245.58M-163.41M-925.48M
Financing Cash Flow0-8.79M-215.42M-247.73M120.41M298.18M

Chemcon Speciality Chemicals Ltd Technical Analysis

Technical Analysis SentimentNegative
Last Price183.85

Price Trends

50DMA208.49Negative
100DMA198.28Negative
200DMA180.74Positive

Market Momentum

MACD-6.98Positive
RSI31.85Neutral
STOCH12.12Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:CHEMCON, the sentiment is Negative. The current price of 183.85 is below the 20-day moving average (MA) of 208.45, below the 50-day MA of 208.49, and above the 200-day MA of 180.74, indicating a neutral trend. The MACD of -6.98 indicates Positive momentum. The RSI at 31.85 is Neutral, neither overbought nor oversold. The STOCH value of 12.12 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:CHEMCON.

Chemcon Speciality Chemicals Ltd Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:CHEMCON against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:VINATIORGAIN:VINATIORGA70OutperformINR 102.97B22.93―0.86%10.98%-5.48%
IN:CHEMCONIN:CHEMCON63NeutralINR 6.73B22.26―3.53%22.25%20.33%
IN:ALKYLAMINEIN:ALKYLAMINE61NeutralINR 81.33B36.11―0.63%5.11%20.64%
IN:PRIVISCLIN:PRIVISCL59NeutralINR 125.34B33.70―0.31%21.63%60.79%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IN:AETHERIN:AETHER55NeutralINR 215.08B90.95――30.76%28.12%
IN:ANURASIN:ANURAS49NeutralINR 129.99B74.35―0.13%51.77%36.90%

* General Sector Average

Performance Comparison

-50%0%50%100%IN:CHEMCONIN:AETHERIN:ALKYLAMINEIN:ANURASIN:PRIVISCLIN:VINATIORGADec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
IN:CHEMCON and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:CHEMCONChemcon Speciality Chemicals Ltd183.85-52.58-22.24%
IN:AETHERAether Industries Ltd.1620.45859.30112.89%
IN:ALKYLAMINEAlkyl Amines Chemicals Limited1590.10-289.30-15.39%
IN:ANURASAnupam Rasayan India Ltd.1141.8061.235.67%
IN:PRIVISCLPrivi Speciality Chemicals Limited3208.65265.379.02%
IN:VINATIORGAVinati Organics Limited993.30-663.32-40.04%

Chemcon Speciality Chemicals Ltd Corporate Events

Chemcon schedules virtual analyst and investor meet for September 23

Sep 18, 2026

Chemcon Speciality Chemicals Ltd has announced that its officials will hold a virtual group meeting with analysts and institutional investors on 23 September 2026 from 4:00 p.m. onwards. The company stated that discussions will be based solely on pub...

Chemcon Speciality Chemicals Holds 37th AGM via Virtual Platform in Line with Regulatory Norms

Sep 17, 2026

Chemcon Speciality Chemicals Limited convened its 37th Annual General Meeting on September 17, 2026, via video conferencing and other audio-visual means. The virtual format aligned with regulatory circulars from the Ministry of Corporate Affairs and...

Chemcon publishes Q1 FY27 unaudited results in newspapers and online

Aug 4, 2026

Chemcon Speciality Chemicals Ltd has published its unaudited financial results for the quarter ended 30 June 2026 in Gujarati daily Loksatta Jansatta and English business daily Business Standard, in line with regulatory disclosure norms. The company...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 06, 2026